Resources

2 Resources for

lacteol

Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First Quarter: Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced financial results for the first quarter of fiscal 2008. All amounts are in U.S. dollars. "We are very pleased with our financial performance in the first quarter of fiscal 2008, which was primarily due to strong sales in our CARAFATE, CANASA...; Tags: Axcan Pharma Inc., CARAFATE, DELURSAN, LACTEOL, PYLERA; Research articles 2008-01-31
Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% Increase Over Fiscal 2006: Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced fourth quarter and year-end financial results. Axcan's fiscal year 2007 was very successful with strong operating results and cash flows. All amounts are in U.S. dollars. "In line with our accomplishments since the beginning of the year, our fourth quarter performance...; Tags: Axcan Pharma Inc., CANASA, DELURSAN, FDA, LACTEOL, PANZYTRAT, PYLERA, ULTRASE; Research articles 2007-11-29